secwatch.observer — SEC 8-K summary
======================================

Issuer:     TuHURA Biosciences, Inc./NV (HURA)
CIK:        0001498382
Form:       8-K
Filed at:   2024-09-09T23:59:59+00:00
Accession:  0000950170-24-104739
Event type: m_and_a
Sentiment:  negative
Materiality: 0.85
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kintara warns of possible bankruptcy if TuHURA merger fails; special meeting Sept 20
--------------------------------------------------------------------------------

- Special meeting to approve merger with TuHURA set for Sept 20, 2024; vote deadline Sept 19 at 11:59 p.m. ET.
- Kintara warns that if merger fails, it may lack capital to continue and could seek bankruptcy protection.
- Under merger terms, Kintara equityholders to own ~2.85% (or ~5.45% with CVR) of combined company; TuHURA holders ~97.15%.
- Combined company expected to trade on Nasdaq as "HURA"; closing expected in Q3 2024.
- Board recommends voting FOR all proposals, including charter amendment and reincorporation to Delaware.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1498382/000095017024104739/0000950170-24-104739-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1498382/000095017024104739/ktra-20240909.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-104739

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer